Auro Pharma Losartan product recall (2021-10-01)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Auro-Losartan 25 mg Tablet
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| AEJ5020001A, AEJ5020002A, AEJ5020003A | Auro-Losartan 50 mg Tablet | - Recalling Firm
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
- Marketing Authorization Holder
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
| DIN 02403331 | Tablet | Losartan Potassium 50 mg |
| AEJ1020001A, AEJ1020002A, AEJ1020003A | Auro-Losartan 100 mg Tablet | - Recalling Firm
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
- Marketing Authorization Holder
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
| DIN 02403358 | Tablet | Losartan Potassium 100 mg |
| AEJ2520001A | Auro-Losartan 25 mg Tablet | - Recalling Firm
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
- Marketing Authorization Holder
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
| DIN 02403323 | Tablet | Losartan Potassium 25 mg |
- Auro-Losartan 25 mg Tablet
- Auro-Losartan 50 mg Tablet
- Auro-Losartan 100 mg Tablet
Presence of impurity (5-(4 '- ((5 - (Azidomethyl) -2-butyl-4-chloro-1H-imidazol-1-yl) methyl)-[1,1' - biphenyl] - 2-yl) - 1H-tetrazole above the acceptable concentration limit in affected lots.